Hapoctasin (buprenorphine): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Hapoctasin 35 microgram/h, transdermal patches

Moderate to severe cancer pain and severe pain which does not respond to non-opioid analgesics

Hapoctasin is not suitable for the treatment of acute pain.

Hapoctasin 52.5 microgram/h, transdermal patches

Moderate to severe cancer pain and severe pain which does not respond to non-opioid analgesics

Hapoctasin is not suitable for the treatment of acute pain.

Hapoctasin 70 microgram/h, transdermal patches

Moderate to severe cancer pain and severe pain which does not respond to non-opioid analgesics

Hapoctasin is not suitable for the treatment of acute pain.


Route of administration: opinion.traitement.transdermal
Molecule: buprenorphine

Patients' opinions on Hapoctasin

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.